Future directions for NK cell therapy Allogeneic NK cell therapy continues to be a promising avenue for adoptive cell immunotherapy in a variety of hematologic and solid cancers.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile